IRIS
BONADONNA, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.931
EU - Europa 3.814
AS - Asia 1.688
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 2
AF - Africa 1
Totale 10.452
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.850
CN - Cina 1.319
SE - Svezia 967
IE - Irlanda 960
UA - Ucraina 511
IT - Italia 487
FI - Finlandia 320
TR - Turchia 273
DE - Germania 263
GB - Regno Unito 194
CA - Canada 81
IN - India 28
SG - Singapore 23
BE - Belgio 19
NL - Olanda 18
AT - Austria 17
CZ - Repubblica Ceca 17
VN - Vietnam 16
EU - Europa 15
FR - Francia 10
IR - Iran 10
HK - Hong Kong 7
RO - Romania 7
ES - Italia 6
RU - Federazione Russa 5
JP - Giappone 4
HR - Croazia 3
DK - Danimarca 2
IL - Israele 2
IQ - Iraq 2
KZ - Kazakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BO - Bolivia 1
CM - Camerun 1
GR - Grecia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
PE - Perù 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 10.452
Salva come PNG Salva come JPEG
Città #
Chandler 1.077
Dublin 952
Beijing 496
Jacksonville 496
Ann Arbor 360
Ashburn 356
Izmir 264
Nanjing 230
Princeton 218
Parma 217
Dearborn 157
Wilmington 156
Boardman 130
New York 119
San Mateo 114
Kunming 70
Toronto 70
Nanchang 67
Woodbridge 63
Shanghai 56
Shenyang 53
Hebei 49
Hefei 44
Helsinki 42
Jiaxing 40
Jinan 34
Los Angeles 33
Seattle 32
Des Moines 31
Milan 30
Changsha 27
Falls Church 26
Guangzhou 26
Bremen 24
Tianjin 22
Houston 21
Norwalk 21
Brussels 19
Dong Ket 16
Piacenza 15
Vienna 15
Grafing 13
Mestre 13
Fremont 12
Zhengzhou 12
Chengdu 11
Hangzhou 10
Pune 10
Rome 9
Ardabil 8
Verona 8
Fuzhou 7
Rockville 7
Wenzhou 7
Augusta 6
Bolzano 6
Brno 6
Dallas 6
Edinburgh 6
Washington 6
Atlanta 5
Chicago 5
Fairfield 5
Istanbul 5
Leawood 5
Neviano degli Arduini 5
Ningbo 5
Redwood City 5
Tappahannock 5
Amsterdam 4
Chongqing 4
Düsseldorf 4
Huskvarna 4
Kocaeli 4
Mumbai 4
Phoenix 4
Senigallia 4
Xian 4
Bologna 3
Borås 3
Haikou 3
Novellara 3
Padova 3
Redmond 3
Strasbourg 3
Taiyuan 3
Taizhou 3
University Park 3
Vicopisano 3
Aachen 2
Acquaviva Picena 2
Almaty 2
Brahmapur 2
Castellarano 2
Collecchio 2
Delhi 2
Frankfurt am Main 2
Hajj Sallum 2
Imola 2
Isola della Scala 2
Totale 6.587
Salva come PNG Salva come JPEG
Nome #
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the area of blood glucose and insulin concentrations 124
Effect of coffee and cocoa-based confectionery containing coffee on markers of cardiometabolic health: results from the pocket-4-life project 113
Claimed effects, outcome variables and methods of measurement for health claims proposed under European community regulation 1924/2006 in the framework of maintenance of skin function 104
Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: Potential relevance to prevention of cardiovascular events 98
Metabolomic Changes after Coffee Consumption: New Paths on the Block 95
Correction: Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects(PLoS ONE (2018)12:8(e0182559) DOI: 10.1371/journal.pone.0182559) 92
Claimed effects, outcome variables and methods of measurement for health claims proposed under Regulation (EC) 1924/2006 in the framework of bone health 88
Effects of TiO2 and Co3O4 Nanoparticles on Circulating Angiogenic Cells 85
Claimed effects, outcome variables and methods of measurement for health claims on foods related to the gastrointestinal tract proposed under regulation (EC) 1924/2006 82
Operation of Randle's cycle in patients with NIDDM 80
Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. 79
Quantification of epicardial fat with cardiac CT angiography and association with cardiovascular risk factors in symptomatic patients: From the ALTER-BIO (alternative cardiovascular bio-imaging markers) registry 79
Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under Regulation (EC) 1924/2006 in the area of oral health 79
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health. 78
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion 77
Total body fat content and fat topography are differently associated with in vivo glucose metabolism in nonobese and obese women. 77
Predictors of insulin sensitivity in type 2 diabetes mellitus 76
ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria 76
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 76
Alterations of glucose metabolism in type 2 diabetes mellitus. An overview. 75
Adipocytes IGFBP-2 expression in prepubertal obese children. 74
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 72
Which is the eligible patient to be treated with pioglitazone? The expert view. 72
Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. 72
Obesity and insulin resistance in man. A dose response study 71
Pathogenesis of NIDDM. A balanced overview. 71
Beta-cell function across the spectrum of glucose tolerance in obese youth. 70
Intracellular glucose metabolism and insulin resistance in obese non-insulin dependent diabetes. Compensatory effects of hyperglycemia and hyperinsulinemia. 69
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in nondiabetic subjects. The GISIR database. 69
Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus 69
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 68
Phasic insulin release and metabolic regulation in type 2 diabetes 68
Influence of cell age and keto-aminic linkage on rapid glycosylation of hemoglobin in human red cell in vitro 68
Fasting plasma glucose variability predicts 10-year survival of Type 2 diabetic patients. The Verona Diabetes Study 67
Transcriptomic analysis of human polarized macrophages: More than one role of alternative activation? 67
Angiotensin-Converting Enzyme genotype and Endothelium-Dependent Vasodilation of Conduit Arteries and Forearm Microcirculation in Humans 67
U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population: The Bruneck study 66
Impaired glucose tolerance, type 2 diabetes mellitus and carotid atherosclerosis. Prospective results from the Bruneck Study 65
In vivo glucose metabolism in obese and type II diabetic subjects with and without hypertension. 65
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. 65
Estimation of organ transport function for recirculating indicator dilution curves 65
Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women 65
Bicarbonate kinetics in humans: identification and validation of athree-compartment model 65
A compartmental model to quantitate in vivo glucose transport in the human forearm 65
Claimed Effects, Outcome Variables and Methods of Measurement for Health Claims on Foods Related to Vision Proposed Under Regulation (EC) 1924/2006 65
Effects of glucosamine infusion on insulin secretion and insulin action in humans 64
Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes. 64
Time dependence of the interaction between lipid and glucose in humans 63
Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings? 63
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 63
Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. 63
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects 63
Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man 62
Effect of chronic treatment with lacidipine or lisinopril on intracellular partitioning of glucose metabolism in type 2 diabetes mellitus 62
Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance 62
Plasma glucose within the normal range is not associated with carotid atherosclerosis. Prospective results in subjects with normal glucose tolerance from the Bruneck Study 62
Effects on nitric oxide production of urolithins, gut-derived ellagitannin metabolites, in human aortic endothelial cells 62
Bioavailability of Bergamot (Citrus bergamia) Flavanones and Biological Activity of Their Circulating Metabolites in Human Pro-Angiogenic Cells 62
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes 62
Effect of coffee and cocoa-based confectionery containing coffee on markers of dna damage and lipid peroxidation products: Results from a human intervention study 62
Relationship between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals. Role of adipose tissue 61
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. 61
Protein metabolism in human obesity: Relationship with glucose and lipid metabolism and with visceral adipose tissue. 61
Pasta Structure Affects Mastication, Bolus Properties, and Postprandial Glucose and Insulin Metabolism in Healthy Adults 61
Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans 60
Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes. Implications for treatment and monitoring of metabolic control 60
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM 60
Impact of Reference Category and Number of Traits in the Cluster on Risk of Coronary Heart Disease in Metabolic Syndrome: Prospective Data from the Bruneck Study. 60
Absorption, Pharmacokinetics, and Urinary Excretion of Pyridines After Consumption of Coffee and Cocoa-Based Products Containing Coffee in a Repeated Dose, Crossover Human Intervention Study 59
Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus 59
Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under European Community Regulation 1924/2006 in the area of appetite ratings and weight management 59
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 58
Insulin sensitivity is not impaired in Mexican-American women without a family history of diabetes 58
Muscle glucose transport and phosphorylation in type 2 diabetic, obese non-diabetic, and genetically predisposed individuals. 58
Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects 58
Insulin resistance and vasodilation in essential hypertension. Studies with adenosine 57
Glucose metabolism in obesity and type 2 diabetes 57
Bariatric surgery or medical therapy for obesity 57
The metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. 57
Metabolic and thermogenic effects of lactate infusion in humans 57
Removal of catheter distortion in multiple indicator dilution studies: a deconvolution-based method and case studies on glucose blood-tissue exchange 57
Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study. 56
The Metabolic Syndrome Is a Risk Indicator of Microvascular and Macrovascular Complications in Diabetes: Results from Metascreen, a multicenter diabetes clinic-based survey. 56
Effect of prolonged overnight fasting on energy metabolism in non-insulin-dependent diabetic and non-diabetic subjects 56
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study 56
High-normal HbA1c is a strong predictor of type 2 diabetes in the general population. 56
Glucose and free fatty acid metabolism in human obesity. Relationship with insulin resistance 56
Telomere length is independently associated with subclinical atherosclerosis in subjects with type 2 diabetes: a cross-sectional study 56
Relationship between insulin and carotid atherosclerosis in the general population: The Bruneck study 55
Insulin causes endothelial dysfunction in humans. Sites and mechanisms 55
A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study 55
First italian consensus statement on diagnosis, prevention an treatment of cardiovascular complications in HIV-infected patients in the HAART era. 55
Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study 54
Ghrelin, insulin sensitivity and postprandial glucose disposal in overweight and obese children. 54
Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population. 54
The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study 54
Intracellular partition of plasma glucose disposal in hypertensive and normotensive subjects with type 2 diabetes mellitus 54
In vivo metabolic defects in non-insulin-dependent diabetes mellitus 54
Variants and haplotypes of TCF7L2 are associated with beta cell function in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).1. 54
Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. 53
Totale 6.650
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.615
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019346 0 0 0 0 0 0 0 0 0 0 331 15
2019/20201.977 343 485 110 28 145 147 191 33 131 222 42 100
2020/20211.363 4 114 173 12 134 150 136 26 226 76 205 107
2021/20221.084 92 38 24 29 47 36 143 128 55 56 18 418
2022/20233.628 357 236 158 299 401 448 23 218 1.297 17 127 47
2023/20241.049 90 136 66 50 113 334 72 96 40 49 3 0
Totale 10.892